Novel gene drives development of different types of ovarian cancer
Researchers at Mayo Clinic Cancer Center have identified a novel gene that can contribute to a woman's susceptibility for developing ovarian cancer. Researchers identified the gene, called HNF1B, through large-scale analysis ...
Cancer
Mar 27, 2013 |
not rated yet |
0
Five genetic variations increase risk of ovarian cancer
An international research collaboration has found five new regions of the human genome that are linked to increased risks for developing ovarian cancer. Duke Medicine researchers played a leading role analyzing genetic information ...
Cancer
Mar 27, 2013 |
not rated yet |
0
Unique study reveals genetic 'spelling mistakes' that increase the risk of common cancers
More than 80 genetic 'spelling mistakes' that can increase the risk of breast, prostate and ovarian cancer have been found in a large, international research study within the framework of the EU Network COGS. For the first ...
Cancer
Mar 27, 2013 |
not rated yet |
0
Night shifts may be linked to increased ovarian cancer risk
Working night shifts might increase the risk of developing ovarian cancer, indicates research published in Occupational and Environmental Medicine.
Cancer
Mar 14, 2013 |
not rated yet |
0
|
Grieving husband pushes bill for unproven remedies
(AP)—After the best-selling Irish novelist Josephine Hart died from ovarian cancer in 2011, her husband was so devastated he often went to her grave to have breakfast.
Other
Mar 13, 2013 |
5 / 5 (2) |
0
SOG: Intraperitoneal chemo ups ovarian cancer survival
(HealthDay)—Intraperitoneal (IP) chemotherapy is associated with improved survival in advanced ovarian cancer compared with standard intravenous (IV) therapy, according to a study presented at the Society ...
Cancer
Mar 12, 2013 |
not rated yet |
0
Many ovarian cancer patients denied by-the-book care, study says
(HealthDay)—Nearly two-thirds of ovarian cancer patients don't receive recommended treatment that could extend their lives, U.S. researchers have found.
Cancer
Mar 12, 2013 |
not rated yet |
0
Cancer-slowing compound also combats malaria, researchers find
An extract from a shrub often used for medicinal purposes in tropical Africa may have lethal effects against a dangerous parasite that transmits malaria, according to a multi-institutional team of scientists ...
Medical research
Mar 08, 2013 |
not rated yet |
0
|
Origin of aggressive ovarian cancer discovered
Cornell University researchers have discovered a likely origin of epithelial ovarian cancer (ovarian carcinoma), the fifth leading cause of cancer death among women in the United States.
Cancer
Mar 06, 2013 |
5 / 5 (1) |
0
|
Chemo given into the abdomen could boost ovarian cancer survival
Chemotherapy given straight into the abdomen of certain ovarian cancer patients could allow them to live an extra three years on average, according to new research published in the British Journal of Cancer.
Cancer
Mar 06, 2013 |
not rated yet |
0
Ob-gyn group lists procedures that may not be needed
(HealthDay)—Five tests and procedures that obstetricians/gynecologists and their patients should question the need for are outlined in a list released by the American College of Obstetricians and Gynecologists ...
Obstetrics & gynaecology
Mar 03, 2013 |
not rated yet |
0
Gene mutation's benefit for ovarian cancer patients may not last: study
(HealthDay)—Although women diagnosed with ovarian cancer who carry a BRCA gene mutation have a short-term survival advantage, this benefit is not reflected in the long-term, according to a new study.
Cancer
Feb 20, 2013 |
not rated yet |
0
Challenge to cancer gene patent fails in Australia
An Australian court Friday dismissed a challenge against the patenting of human genetic material in a landmark case which has devastated a cancer group that says it could stifle research.
Cancer
Feb 15, 2013 |
not rated yet |
1
Nanotech'ed RNA drug reduces ovarian cancer tumors by 83 percent
By loading fragile RNA into silicon nanoparticles, researchers from The Methodist Hospital and two other institutions found a new drug delivery system can reduce the size of ovarian tumors by as much as 83 ...
Cancer
Feb 14, 2013 |
not rated yet |
0
|
Consumers have few negative reactions to the results of genetic testing for cancer mutations
A 23andMe study of consumers' reactions to genetic testing found that even when the tests revealed high-risk mutations in individuals, those individuals had few negative reactions to the news. Instead of inducing serious ...
Cancer
Feb 12, 2013 |
not rated yet |
0
